Bronchoalveolar lavage triacetylfusarinine C (TAFC) determination for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies

Thomas Orasch, Juergen Prattes, Klaus Faserl, Susanne Eigl, Wiebke Düttmann, Herbert Lindner, Hubertus Haas, Martin Hoenigl, Thomas Orasch, Juergen Prattes, Klaus Faserl, Susanne Eigl, Wiebke Düttmann, Herbert Lindner, Hubertus Haas, Martin Hoenigl

No abstract available

Keywords: Antifungal prophylaxis; Antimould treatment; Galactomannan; Lateral flow device; Siderophores.

Conflict of interest statement

Conflicts of interest

M. Hoenigl received research grants from Merck, Pfizer and Gilead; served on the speakers’ bureau of Pfizer, Gilead, Astellas, Basilea and Merck and received travel grants from Astellas, Merck, Gilead and Pfizer.

J. Prattes received travel grant from Pfizer and consulting fee from Gilead.

All other authors no conflict.